rt-PCR method for diagnosis and follow-up of hematological malignancies: First approach in Bangladesh

Authors

  • Tanvira Afroze Sultana Laboratory Department, Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM), Shahbag, Dhaka, Bangladesh.
  • Md. Abdul Mottalib Laboratory Department, Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM), Shahbag, Dhaka, Bangladesh.
  • Md. Sirazul Islam Laboratory Department, Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM), Shahbag, Dhaka, Bangladesh.
  • Mohiuddin Ahmed Khan Department of Hematology, Dhaka Medical College, Dhaka, Bangladesh.
  • Subhagata Choudhury Laboratory Department, Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM), Shahbag, Dhaka, Bangladesh.

DOI:

https://doi.org/10.3329/bmrcb.v34i1.1162

Abstract

Nested reverse-transcriptase polymerase chain reaction (rt-PCR) was performed on 58 leukemia patients at BIRDEM Laboratory, as a pioneering work in Bangladesh. Thirty of them were examined for the presence of BCR-ABL being clinically and morphologically diagnosed as chronic myeloid leukemia (CML) and 28 for PML-RARα fusion transcripts being clinically and morphologically diagnosed as acute promyelocytic leukemia (APL/ AML M3). The cases were selected for targeted therapy with imatinib mesylate and all-Trans retinoic acid (ATRA) to treat CML and APL respectively. Samples were received either before commencement or during therapy. In the positive cases, amplified DNA products were visible after gel electrophoresis and were reported accordingly. In case of BCR-ABL, positive results were found for five out of six (83.33%) untreated cases and 11 out of 24 (45.83%) treated cases. Positive results for PML-RARα were found for 12 out of 14 (85.70%) untreated cases and 11 out of 16 (68.75%) treated cases. A strong positive correlation was found between duration of treatment and negativity of PCR results in both the cases. In present times, the detection of minimal residual disease in patients undergoing treatment for hematological malignancies has become an important goal, not only to monitor the effectiveness of therapy but also to detect an impending relapse. This is the first time in Bangladesh that rt-PCR method is being employed to detect or monitor the presence of abnormal fusion genes in hematological malignancies.

Keywords: Bangladesh; malignancy; rt-pcr

DOI: 10.3329/bmrcb.v34i1.1162

Bangladesh Med Res Counc Bull 2008; 34: 1-11

Downloads

Download data is not yet available.
Abstract
161
PDF
324

Downloads

Published

2008-09-16

How to Cite

Sultana, T. A., Mottalib, M. A., Islam, M. S., Khan, M. A., & Choudhury, S. (2008). rt-PCR method for diagnosis and follow-up of hematological malignancies: First approach in Bangladesh. Bangladesh Medical Research Council Bulletin, 34(1), 1–11. https://doi.org/10.3329/bmrcb.v34i1.1162

Issue

Vol. 34 No. 1 (2008)

Section

Research Papers

License

Authors who publish with this journal agree to the following terms.

Authors retain copyright and grant the journal right of first publication.

Creative Commons Licence
Articles in the Bangladesh Medical Research Council Bulletin are licensed under a Creative Commons Attribution 4.0 International License (CC-BY) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).